Jake Jorgovan

MARCH 23, 2024

is a reputable firm specializing in consulting, recruitment, and personnel placement within the biopharmaceutical sector. Choosing JGB Biopharma for your recruitment and consulting needs means partnering with a firm that possesses an in-depth understanding of the biopharmaceutical and related industries. JGB Biopharma Consulting, Inc.

Biotechnology 130

Biotechnology Life science Biotech Biopharma 130

Jake Jorgovan

NOVEMBER 27, 2023

Biopharmaceutical Consulting: Supporting every aspect of the biopharma value chain, including R&D, operations, manufacturing, commercialization, and mergers and acquisitions (M&A).

Life science 130

Life science Biopharmaceuticals Biotech Mergers and acquisition activities 130

INSEAD Knowledge

DECEMBER 4, 2022

Bad for business The negative effect of peer competition on firm performance has previously been documented in the biopharmaceutical industry and the medical device industry.

Collaboration 119

Collaboration Biopharmaceuticals Finance 119

Frost & Sullivan

DECEMBER 16, 2020

Furthermore, LabCorp Drug Development draws on its deep expertise in antiviral drugs and vaccines, as well as partners with biopharmaceutical companies to develop treatment and vaccines for COVID-19 through improved detection methods.”

Biopharmaceuticals 98

Biopharmaceuticals Life science Contract research organization Government 98

Frost & Sullivan

JULY 19, 2021

Leveraging a leading suite of end-to-end biopharmaceutical development services covering patient-focused clinical trial design and decentralized clinical trial (DCT) strategies, the company has helped develop 198 of the 200 top-selling biopharmaceuticals in the market. About Parexel International Corporation.

Biopharmaceuticals 52

Biopharmaceuticals Life science Contract research organization 52

Frost & Sullivan

APRIL 25, 2023

Emmes is a full-service, global Clinical Research Organization (CRO) committed to promoting public health and biopharmaceutical innovation. The company collaborates with biopharmaceutical, governmental, non-profit, and academic organizations to enhance its value proposition and meet client demands.

Biopharmaceuticals 52

Biopharmaceuticals Biopharma Biotechnology Contract research organization 52

Frost & Sullivan

JUNE 22, 2021

Invest in Blood Transfusion and Apheresis Membranes to Accelerate Revenue Growth : The increasing demand for blood plasma to create plasma-derived biopharmaceutical products will drive the demand for apheresis and transfusion membranes.

Biopharmaceuticals 64

Biopharmaceuticals Government 64

Frost & Sullivan

NOVEMBER 29, 2022

Automated processes, remote monitoring, and digital supply chains accelerate biomanufacturing rates of biopharmaceuticals.”. “Digitalization improves the entire value chain of manufacturing biologics, competitive generic therapy (CGT) products, and vaccines,” said Neeraja Vettekudath, Healthcare Research Analyst at Frost & Sullivan.

Biopharmaceuticals 52

Biopharmaceuticals Government 52

Frost & Sullivan

JULY 23, 2024

With nearly 25 years of experience, Aragen assists its global clients in various industries, such as pharmaceutical, biotech, and agrochemical, throughout the biopharmaceutical lifecycle, offering comprehensive solutions spanning small and large molecules.

Life science 52

Life science Biotech Biopharmaceuticals Collaboration 52

Frost & Sullivan

DECEMBER 19, 2023

Parexel has more than 40 years of experience and 21,000+ dedicated professionals globally who successfully collaborate with biopharmaceutical leaders to design and conduct patient-focused clinical trials worldwide. Parexel leverages its in-depth RWE knowledge to identify evidence gaps and formulate evidence-generation strategies.

Biopharmaceuticals 52

Biopharmaceuticals Insurance Collaboration Life science 52

Jake Jorgovan

NOVEMBER 15, 2023

Industries: Pharmaceutical, Biotechnology, Medical Devices, Chemical, Agrochemical, Environmental, Agricultural, Engineering, Life Sciences, Clinical, Personal Care, FMCG, Forensic, Food & Beverage, Energy, Biopharmaceuticals, Diagnostics, Veterinary, Medical Technology, Tobacco, Laboratory Services, Aesthetics, Geology & Earth Sciences, Chemistry (..)

Biopharma 130

Biopharma Life science Biotechnology Biotech 130

Frost & Sullivan

MAY 16, 2022

It offers novel precision health and wellness software-as-a-service (SaaS) solutions to patients, healthcare providers (HCPs), employers, health plans, and biopharmaceuticals. The company provides a precision health-specific healthcare system and governance to improve access and awareness, thus driving adoption.

Biopharmaceuticals 52

Biopharmaceuticals Insurance Ecosystems Government 52

Frost & Sullivan

SEPTEMBER 4, 2024

Phesi delivers clinical development analytical products and services to biopharmaceutical companies worldwide. . – Sept 4, 2024 – Frost & Sullivan has recognized Phesi with the 2024 Global Enabling Technology Leadership Award after analyzing the AI-enabled clinical trial design industry.

Life science 52

Life science Biopharmaceuticals Biotech Utilities 52

Frost & Sullivan

AUGUST 23, 2023

The combination of claims and EHR data, an expanding incorporation of genomic insights, and a continued emphasis on RWE and diversity, make Optum the partner of choice for biopharmaceutical (biopharma) companies seeking to create higher-value treatments while accelerating their time to market.

Life science 52

Life science Biopharmaceuticals Biopharma Partnering capability and readiness 52

LaVoie Health Science Blog

NOVEMBER 12, 2020

In his new role, Heins will provide senior level communications counsel to LHS’s growing roster of biopharmaceutical, medical technology, health IT, and health care services clients.

Biopharmaceuticals 52

Biopharmaceuticals Channels and alliances Global alliance 52

LaVoie Health Science Blog

OCTOBER 5, 2020

Strong detail oriented public relations/communications professional needed for growing life science/biopharmaceutical practice. Join a health science focused integrated communications agency and be part of the agency’s second phase of growth.

Biopharmaceuticals 40

Biopharmaceuticals Biotechnology Life science Finance 40

Frost & Sullivan

MAY 3, 2023

With over 20 years of experience and more than 450 people managing 39 geographical locations throughout the Asia-Pacific region, USA, and Europe, George Clinical provides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration, and post-marketing trials.

Contract research organization 52

Contract research organization Biopharmaceuticals Biopharma Business development 52

Frost & Sullivan

JULY 9, 2024

Its cloud-based EDC, RTSM, CTMS, and eCOA integrated platform offer biopharmaceutical sponsors a unified view of trial workflows, thus improving efficiency. The company’s AI-enabled eClinical platform employs advanced automation technologies to speed up clinical study timelines and enhance visibility into all aspects of the process.

Life science 52

Life science Biopharmaceuticals Biotechnology Contract research organization 52

Frost & Sullivan

APRIL 3, 2024

Wuxi STA expanded its partnership with Ark Biopharmaceutical for the commercial supply of Ziresovir, a first-in-class oral antiviral for respiratory syncytial virus, which has completed the phase III clinical trial globally, for which a New Drug Application has been accepted and granted Priority Review by the China NMPA.

Biopharmaceuticals 59

Biopharmaceuticals Biopharma Biotechnology Life science 59

Frost & Sullivan

AUGUST 6, 2023

“The company understands the intricacies of conducting clinical trials for innovative biopharmaceutical products, gene and cell therapies, and other advanced therapies.

Biotechnology 52

Biotechnology Biotech Contract research organization Biopharmaceuticals 52

Frost & Sullivan

APRIL 11, 2022

The platform allows faster and more cost-effective development of new biopharmaceuticals. It extended this expertise to developing a technology platform that enables discovery in a range of growing markets through single-cell analysis.

Biopharmaceuticals 52

Biopharmaceuticals System integrators Collaboration 52

Frost & Sullivan

JUNE 24, 2024

Biomarker Driven Treatments for Lung Cancers Continue to Gain Prominence The impetus in the field of lung cancer research is sustained by the emergence of new data, which showcased the encouraging clinical outcomes presented by major biopharmaceutical companies.

Biopharmaceuticals 52

Biopharmaceuticals Biopharma Collaboration Ecosystems 52

Phoenix Consulting Group

JUNE 9, 2020

The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership of more than a dozen leading biopharmaceutical companies and government agencies are collaborating under the direction of the National Institute of Health to coordinate development of treatments and vaccines for Covid19.

Ecosystems 52

Ecosystems Channels and alliances Biopharmaceuticals Insurance 52

Frost & Sullivan

AUGUST 9, 2021

The US digital therapeutics market is estimated to witness more than three-and-a-half-fold growth reaching $4.54 billion by 2025, at a CAGR of 29.8%, finds Frost & Sullivan. Santa Clara, Calif. –

Life science 98

Life science Biopharma Government Biopharmaceuticals 98

Frost & Sullivan

MARCH 30, 2021

Pharmaceuticals and biotechnology, IVD, advanced medical technologies, medical imaging and informatics, and digital health expected to hit over $2.6 trillion by 2025. Santa Clara, Calif.

Biotechnology 98

Biotechnology Life science Government Biopharmaceuticals 98

Frost & Sullivan

AUGUST 9, 2021

The US digital therapeutics market is estimated to witness more than three-and-a-half-fold growth reaching $4.54 billion by 2025, at a CAGR of 29.8%, finds Frost & Sullivan. Santa Clara, Calif. –

Life science 90

Life science Biopharma Government Biopharmaceuticals 90

Frost & Sullivan

MARCH 30, 2021

Pharmaceuticals and biotechnology, IVD, advanced medical technologies, medical imaging and informatics, and digital health expected to hit over $2.6 trillion by 2025. Santa Clara, Calif.

Biotechnology 52

Biotechnology Life science Government Biopharmaceuticals 52

Frost & Sullivan

AUGUST 28, 2024

BiBo Pharma is breaking capacity barriers and reducing antibody drug production costs from the international average of hundreds of dollars to just $10 per gram, offering disruptive solutions to global biopharmaceutical companies. times compared to the current 15,000L (total volume) standard in large-scale biopharmaceutical production.

Biopharmaceuticals 52

Biopharmaceuticals Construction Engineering Insurance 52

Jake Jorgovan

JUNE 3, 2024

Orphan Drug Consulting: Orphan Drug Consulting offers tailored consulting services across strategic planning, supply chain management, and regulatory compliance, specializing in guiding pharmaceutical and biopharmaceutical companies through the challenges of launching orphan drugs globally.

Biopharma 130

Biopharma Biotech Biopharmaceuticals Life science 130

LaVoie Health Science Blog

DECEMBER 16, 2024

Biotech Showcase is a premier investor conference committed to creating a platform for private and micro-mid-cap biotechnology companies, offering unique opportunities to showcase innovations and engage one-to-one with investors and biopharmaceutical executives.

Biopharmaceuticals 52

Biopharmaceuticals Biotechnology Life science Biotech 52

Jake Jorgovan

NOVEMBER 28, 2023

The Windshire Group: Is a comprehensive life science and management consulting firm founded in 2011 focusing on the pharmaceutical and biopharmaceutical industries. Their global presence and diverse range of services ensure a holistic and effective strategy for any project in the pharmaceutical and biopharmaceutical sectors.

Life science 130

Life science Biopharmaceuticals Biotech Partnering capability and readiness 130

LaVoie Health Science Blog

DECEMBER 21, 2023

Biotech Showcase is a premier investor conference committed to creating a platform for private and micro-mid-cap biotechnology companies, offering unique opportunities to showcase innovations and engage one-to-one with investors and biopharmaceutical executives.

Biopharmaceuticals 59

Biopharmaceuticals Biotechnology Life science Biotech 59

Jake Jorgovan

FEBRUARY 5, 2025

Updated: February 2025 Biopharmaceutical consultants and consulting firms play a pivotal role in guiding companies through the intricate landscape of drug development, regulatory compliance, and market strategies. Alpha Apex Group Alpha Apex Group , Leaders in BioPharmaceutical Consulting.

Biopharmaceuticals 130

Biopharmaceuticals Biopharma Biotech Life science 130

Jake Jorgovan

FEBRUARY 5, 2025

is a reputable firm specializing in consulting, recruitment, and personnel placement within the biopharmaceutical sector. Choosing JGB Biopharma for your recruitment and consulting needs means partnering with a firm that possesses an in-depth understanding of the biopharmaceutical and related industries. JGB Biopharma Consulting, Inc.

Biotechnology 130

Biotechnology Life science Biotech Biopharma 130

Frost & Sullivan

FEBRUARY 24, 2025

As these innovations gain traction, biopharmaceutical companies, research institutions, and healthcare investors must act now to stay ahead. Instead, next-generation therapeuticssuch as monoclonal antibodies, RNA-based treatments, and phage therapyare emerging as breakthrough solutions. Whats Driving the Shift?

Biotechnology 52

Biotechnology Biopharmaceuticals Strategic partnership 52

Jake Jorgovan

FEBRUARY 2, 2025

The Windshire Group: Is a comprehensive life science and management consulting firm founded in 2011 focusing on the pharmaceutical and biopharmaceutical industries. Their global presence and diverse range of services ensure a holistic and effective strategy for any project in the pharmaceutical and biopharmaceutical sectors.

Life science 130

Life science Biopharmaceuticals Biotech Partnering capability and readiness 130